Several definitive treatment options are available for prostate cancer, but geographic access to those options is not uniform. We created maps illustrating provider practice patterns relation to patients and assessed the influence of distance to treatment receipt.
ASTRO is pleased to recognize the following Emerging Advocacy Grassroots Leadership (EAGL) grantees, and are looking forward to welcoming them to Washington, D.C. in May…
ASTRO Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features.
No matter your interests or career stage, There are many ways to participate in ASTRO. Here are the top 12 ways to get involved.
ASTRO Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features. Edited by Salma…
Register for ASTRO’s radiopharmaceutical webinar series.
ASTROnews is the Society’s quarterly news magazine covering happenings in ASTRO, cancer care and the specialty of radiation oncology.
Register to attend and view details for booking your accommodations for Advocacy Day 2024.
Register for ASTRO’s radiopharmaceutical webinar series.
ASTRO Awards two grants of up to $10,000 each year to patient support organizations in the cities that host the Annual Meeting. Learn more and…
The POP-RT phase III randomized trial showed improved biochemical failure-free survival and metastasis-free survival with whole pelvic radiotherapy (WPRT) versus prostate-only radiotherapy (PORT) for high/very…
